142 related articles for article (PubMed ID: 16781151)
1. Identification of small-molecule inhibitors of the Abeta-ABAD interaction.
Xie Y; Deng S; Chen Z; Yan S; Landry DW
Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
[TBL] [Abstract][Full Text] [Related]
5. Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction.
Yan Y; Liu Y; Sorci M; Belfort G; Lustbader JW; Yan SS; Wang C
Biochemistry; 2007 Feb; 46(7):1724-31. PubMed ID: 17253767
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
Chen X; Yan SD
IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme.
Marques AT; Fernandes PA; Ramos MJ
Bioorg Med Chem; 2008 Nov; 16(21):9511-8. PubMed ID: 18835182
[TBL] [Abstract][Full Text] [Related]
8. The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
Muirhead KE; Borger E; Aitken L; Conway SJ; Gunn-Moore FJ
Biochem J; 2010 Feb; 426(3):255-70. PubMed ID: 20175748
[TBL] [Abstract][Full Text] [Related]
9. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
Benek O; Musílek K; Kuca K
Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
[TBL] [Abstract][Full Text] [Related]
10. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.
Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde.
Murakami Y; Ohsawa I; Kasahara T; Ohta S
Neurobiol Aging; 2009 Feb; 30(2):325-9. PubMed ID: 17707551
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial β-amyloid in Alzheimer's disease.
Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
[TBL] [Abstract][Full Text] [Related]
15. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
Morsy A; Trippier PC
J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
[TBL] [Abstract][Full Text] [Related]
17. In silico-designed novel non-peptidic ABAD L
Viswanath ANI; Kim T; Jung SY; Lim SM; Pae AN
Chem Biol Drug Des; 2017 Dec; 90(6):1041-1055. PubMed ID: 28660722
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
Chen JX; Yan SD
Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
[TBL] [Abstract][Full Text] [Related]
19. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457
[No Abstract] [Full Text] [Related]
20. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol.
Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J
PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
